Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India
Authors
Keywords
-
Journal
LANCET INFECTIOUS DISEASES
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-04-05
DOI
10.1016/s1473-3099(22)00124-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature
- (2022) Himanshu Pruthi et al. MYCOPATHOLOGIA
- The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
- (2022) Martin Hoenigl et al. Lancet Microbe
- Has the mortality from pulmonary mucormycosis changed over time? A systematic review and meta-analysis
- (2021) Valliappan Muthu et al. CLINICAL MICROBIOLOGY AND INFECTION
- Is high-dose glucocorticoid beneficial in COVID-19?
- (2021) Valliappan Muthu et al. EUROPEAN RESPIRATORY JOURNAL
- COVID‐19–associated pulmonary aspergillosis: a prospective single‐center dual case series
- (2021) Eelco F. J. Meijer et al. MYCOSES
- Autopsy Proven Pulmonary Mucormycosis Due to Rhizopus microsporus in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy
- (2021) Christoph Zurl et al. Journal of Fungi
- Role of flexible bronchoscopy in the diagnosis of invasive fungal infections
- (2021) Valliappan Muthu et al. MYCOSES
- In Vitro Antifungal Drug Resistance Profiles of Clinically Relevant Members of the Mucorales (Mucoromycota) Especially with the Newer Triazoles
- (2021) Andrew M. Borman et al. Journal of Fungi
- Aspergillus terreus Species Complex
- (2021) Cornelia Lass-Flörl et al. CLINICAL MICROBIOLOGY REVIEWS
- Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis
- (2021) Paul E. Verweij et al. INTENSIVE CARE MEDICINE
- Relationship between chest computed tomography findings and clinical conditions of coronavirus disease (COVID‐19): A multicentre experience
- (2021) Nilgün Yılmaz Demirci et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations
- (2021) Nurettin Bayram et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- Epidemiology and Antifungal Susceptibilities of Mucoralean Fungi in Clinical Samples from the United States
- (2021) Hamid Badali et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World
- (2021) Valliappan Muthu et al. MYCOPATHOLOGIA
- Mucormycosis and COVID‐19: An epidemic within a pandemic in India
- (2021) Lav Selarka et al. MYCOSES
- Is there an association between zinc and COVID‐19–associated mucormycosis? Results of an experimental and clinical study
- (2021) Valliappan Muthu et al. MYCOSES
- ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐ and middle‐income countries
- (2021) Shivaprakash M. Rudramurthy et al. MYCOSES
- COVID-19-associated mucormycosis presenting to the Emergency Department—an observational study of 70 patients
- (2021) A Ramaswami et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- CT Findings of COVID-19–associated Pulmonary Mucormycosis: A Case Series and Literature Review
- (2021) Mandeep Garg et al. RADIOLOGY
- Cavity in pulmonary mucormycosis: Is it rare?
- (2021) Valliappan Muthu et al. TROPICAL DOCTOR
- Absence of Case of Mucormycosis (March 2020–May 2021) under strict protocol driven management care in a COVID-19 specific tertiary care intensive care unit
- (2021) Bindu Mulakavalupil et al. Diabetes & Metabolic Syndrome-Clinical Research & Reviews
- Diabetes mellitus and Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): A wake-up call from Egypt
- (2021) Mostafa Alfishawy et al. Diabetes & Metabolic Syndrome-Clinical Research & Reviews
- Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
- (2021) Andre K. Johnson et al. Medical Mycology Case Reports
- High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial)
- (2021) Sahajal Dhooria et al. EUROPEAN RESPIRATORY JOURNAL
- Follow‐up CT of “reversed halo sign” in SARS‐CoV‐2 delta VOC pneumonia: A report of two cases
- (2021) Jing Wu et al. JOURNAL OF MEDICAL VIROLOGY
- Serum iron indices in COVID‐19‐associated mucormycosis: A case–control study
- (2021) Mohan Kumar H et al. MYCOSES
- Results from a national survey on COVID‐19‐associated mucormycosis in Germany: 13 patients from six tertiary hospitals
- (2021) Danila Seidel et al. MYCOSES
- COVID‐19–associated mucormycosis, diabetes and steroid therapy: Experience in a single centre in Western Mexico
- (2021) Salvador Guzmán‐Castro et al. MYCOSES
- Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study
- (2021) Jean-Pierre Gangneux et al. Lancet Respiratory Medicine
- Global Prevalence of COVID-19-Associated Mucormycosis (CAM): Living Systematic Review and Meta-Analysis
- (2021) Salman Hussain et al. Journal of Fungi
- COVID-19-Associated Mucormycosis (CAM): Case-Series and Global Analysis of Mortality Risk Factors
- (2021) Abanoub Riad et al. Journal of Fungi
- Clinical features of pulmonary mucormycosis in patients with different immune status
- (2020) Min Peng et al. Journal of Thoracic Disease
- Bronchoscopy in COVID-19 Patients with Invasive Mechanical Ventilation: A Center Experience
- (2020) Alfons Torrego et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pharmacokinetics and Pharmacodynamics of Posaconazole
- (2020) Lu Chen et al. DRUGS
- Evaluation of MucorGenius® mucorales PCR assay for the diagnosis of pulmonary mucormycosis
- (2020) Hélène Guegan et al. JOURNAL OF INFECTION
- The Reversed Halo Sign and COVID-19: Possible Histopathological Mechanisms Related to the Appearance of This Imaging Finding
- (2020) Anderson Ribeiro de Sales et al. ARCHIVOS DE BRONCONEUMOLOGIA
- Transforming a General Hospital to an Infectious Disease Hospital for COVID-19 Over 2 Weeks
- (2020) Navin Pandey et al. Frontiers in Public Health
- Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations
- (2020) Christoph Zurl et al. Journal of Fungi
- Safety and Efficacy of Bronchoscopy in Critically Ill Patients with Coronavirus Disease 2019
- (2020) Stephanie H. Chang et al. CHEST
- Bronchoscopy safety precautions for diagnosing COVID‐19 associated pulmonary aspergillosis—A simulation study
- (2020) Philipp Koehler et al. MYCOSES
- Molecular identification of pathogenic fungi in formalin-fixed and paraffin-embedded tissues
- (2020) Joseph Jillwin et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
- (2020) Philipp Koehler et al. LANCET INFECTIOUS DISEASES
- Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis
- (2020) Xun-Jie Cao et al. Biomed Research International
- Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC/MSGERC
- (2020) Barbara D Alexander et al. CLINICAL INFECTIOUS DISEASES
- Factors affecting surgical resection and treatment outcomes in patients with pulmonary mucormycosis
- (2019) Hayoung Cho et al. Journal of Thoracic Disease
- Posaconazole Salvage Therapy: The Posifi Study
- (2019) Jesús Fortun et al. MYCOSES
- An aero mycological analysis of Mucormycetes in indoor and outdoor environments of northern India
- (2019) Hariprasath Prakash et al. MEDICAL MYCOLOGY
- Cut it out! Thoracic Surgeon's Approach to Pulmonary Mucormycosis and the Role of Surgical Resection in Survival
- (2019) Ashrit Multani et al. MYCOSES
- Comparison of Clinical Manifestation, Diagnosis, and Outcomes of Invasive Pulmonary Aspergillosis and Pulmonary Mucormycosis
- (2019) Chun-Yu Lin et al. Microorganisms
- A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India
- (2019) A. Patel et al. CLINICAL MICROBIOLOGY AND INFECTION
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
- (2019) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- Pulmonary Mucormycosis: Radiologic Features at Presentation and Over Time
- (2018) Mark M. Hammer et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Surgical Treatment of Multifocal Pulmonary Mucormycosis
- (2018) Sara E.A. Mills et al. ANNALS OF THORACIC SURGERY
- Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole
- (2018) Matthew W. McCarthy et al. CLINICAL PHARMACOKINETICS
- QPCR detection of Mucorales DNA in bronchoalveolar lavage fluid to diagnose pulmonary mucormycosis
- (2018) Emeline E Scherer et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Challenges in the diagnosis and treatment of mucormycosis
- (2018) A Skiada et al. MEDICAL MYCOLOGY
- Mucormycoses pulmonaires au cours des traitements de leucémies aiguës. Analyse rétrospective d’une série de 25 patients
- (2018) D. Caillot et al. REVUE DES MALADIES RESPIRATOIRES
- Diagnosis of invasive mold diseases in patients with hematological malignancies using Aspergillus , Mucorales, and panfungal PCR in BAL
- (2018) Elisabeth Wehrle-Wieland et al. Transplant Infectious Disease
- Pulmonary mucormycosis: serial morphologic changes on computed tomography correlate with clinical and pathologic findings
- (2017) Bo Da Nam et al. EUROPEAN RADIOLOGY
- Diagnosing filamentous fungal infections in immunocompromised patients applying computed tomography-guided percutaneous lung biopsies: a 12-year experience
- (2017) Cornelia Lass-Flörl et al. INFECTION
- Antifungal resistance in mucorales
- (2017) E. Dannaoui INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis
- (2017) Wei Zhou et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Chronic pulmonary mucormycosis: an emerging fungal infection in diabetes mellitus
- (2017) Nousheen Iqbal et al. Journal of Thoracic Disease
- Diagnostic Performance of Contrast Enhanced Pulmonary Computed Tomography Angiography for the Detection of Angioinvasive Pulmonary Aspergillosis in Immunocompromised Patients
- (2017) C. Henzler et al. Scientific Reports
- Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF)
- (2016) L. Millon et al. CLINICAL MICROBIOLOGY AND INFECTION
- Diagnostic value of (1 → 3)-β-D-glucan in bronchoalveolar lavage fluid for invasive fungal disease: A meta-analysis
- (2016) Xin-yu Shi et al. RESPIRATORY MEDICINE
- Multicenter Evaluation of MIC Distributions for Epidemiologic Cutoff Value Definition To Detect Amphotericin B, Posaconazole, and Itraconazole Resistance among the Most Clinically Relevant Species of Mucorales
- (2015) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Challenges in the management of invasive pulmonary zygomycosis: the Alfred experience
- (2015) Pankaj Saxena et al. ANZ JOURNAL OF SURGERY
- Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis
- (2015) J. Jung et al. CLINICAL MICROBIOLOGY AND INFECTION
- Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis
- (2015) F. Lanternier et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease
- (2015) Oliver A. Cornely et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Feasibility and outcome of CT-guided lung biopsy in patients with hematological diseases and suspected fungal pneumonia
- (2013) Sanjeev Kumar Sharma et al. Journal of Infection in Developing Countries
- In VitroandIn VivoActivities of Posaconazole and Amphotericin B in a Murine Invasive Infection by Mucor circinelloides: Poor Efficacy of Posaconazole
- (2012) Valentina Salas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bronchoscopy as an indicator of tracheobronchial fungal infection in non-neutropenic intensive-care unit patients
- (2012) Ö. Yazicioğlu Moçin et al. CLINICAL MICROBIOLOGY AND INFECTION
- Antifungal Susceptibility and Phylogeny of Opportunistic Members of the Order Mucorales
- (2011) Roxana G. Vitale et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Zygomycosis: conventional laboratory diagnosis
- (2009) C. Lass-Flörl CLINICAL MICROBIOLOGY AND INFECTION
- Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
- (2008) Brahm H. Segal et al. CLINICAL INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started